to develop an Uzbek version of the OABSS questionnaire and to determine its effectiveness as a diagnostic tool for overactive bladder (OAB).

overactive bladder, validation studies, questionnaires, diagnostics

Leron E, Weintraub AY, Mastrolia SA, Schwarzman P. Overactive bladder syndrome: Evaluation and management. Curr Urol. 2018;11:117–125.

Abrams P, Kelleher CJ, Kerr LA, Rogers RG. Overactive bladder significantly affects quality of life. Am J Manag Care. 2000;6(Suppl):S580–S590.

Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87:760–766.

Coyne KS, Sexton CC, Kopp ZS, Ebel Bitoun C, Milsom I, Chapple C. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: Results from EpiLUTS. BJU Int. 2011;108:1459–1471.

Drake MJ. Do we need a new definition of the overactive bladder syndrome? ICI RS 2013. Neurourol Urodyn. 2014;33:622–624.

Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU Guideline amendment 2019. J Urol. 2019;202:558–563.

Van Dijk MM, Wijkstra H, Debruyne FM, De La Rosette JJ, Michel MC. The role of nocturia in the quality of life of men with lower urinary tract symptoms. BJU Int. 2010;105:1141–1146.

Cerruto MA, Asimakopoulos AD, Artibani W, Del Popolo G, La Martina M, Carone R, Finazzi Agrò E. Insight into new potential targets for the treatment of overactive bladder and detrusor overactivity. Urol Int. 2012;89:1–8.

Robinson D, Cardozo L. Managing overactive bladder. Climacteric. 2019;22:250–256.

Burkhard FC, Bosch JLHR, Cruz F, Lemack GE, Nambiar AK, Thiruchelvam N, Tubaro A, Ambühl D, Bedretdinova DA, Farag F, et al. Urinary Incontinence in Adults. EAU Guidelines. Presented at the EAU Annual Congress Amsterdam, 2020. Available at: https://uroweb.org/guideline/urinary-incontinence/. Accessed March 21, 2021.

Abboudi H, Fynes MM, Doumouchtsis SK. Contemporary therapy for the overactive bladder. Obstet Gynaecol. 2011;13:98–106.

Wróbel A, Skorupska K, Rechberger E, et al. Reliability of the Polish version of the Overactive Bladder Symptom Score (OABSS) questionnaire. Int Urogynecol J. 2019;30:2135–2139.

Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA. Short forms to assess quality of life and symptom distress for urinary incontinence in women: The Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Neurourol Urodyn. 1995;14:131–139.

ICIQ-OAB questionnaires. Available from: https://iciq.net/iciq-oab

Homma Y, Fujimura T. Linguistic validation of the English version of the overactive bladder symptom score. Int J Urol. 2014;21:229.

Homma Y, Yoshida M, Seki N, et al. Symptom assessment tool for overactive bladder syndrome – Overactive Bladder Symptom Score. Urology. 2006;68:318–323.

Lohr KN, Aaronson NK, Alonso J, Burnam MA, Patrick DL, Perrin EB, et al. Evaluating quality-of-life and health status instruments: Development of scientific review criteria. Clin Ther. 1996;18:979–992.

Koo TK, Li MY. A guideline for selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15:155–163.